Introduction 42
Transmissible spongiform encephalopathies (TSE), or prion diseases, are fatal neurodegenerative disorders 43 occurring in small ruminants (scrapie), cattle (bovine spongiform encephalopathy -BSE), or humans 44 (Creutzfeldt-Jakob disease -CJD). The key event in TSE is the conversion of a normal cellular protein 45 (PrP C ) into an abnormal isoform (PrP Sc ) which accumulates in tissues in infected individuals. According to 46 the prion concept, abnormal PrP is the causative agent of TSEs (11). 47 7 intercurrent health problems were treated by qualified veterinarians and euthanased if the condition was not 125 curable. 126
Dead animals were systematically necropsied and central nervous system (CNS), a variety of lymphoid 127 (mesenteric lymph node, tonsil, Prescapular lymph node, Peyer's patches) and non-lymphoid tissues were 128 collected ( Table 1) . Half of the samples were formalin fixed while the other half was stored frozen (-20°C) . 129
130

PrP
Sc Immunohistochemestry (IHC) and PrP res ELISA detection 131
Sc IHC detection was performed as described in Lacroux et al using 8G8 antibody raised against human 132 recombinant PrP protein and specifically recognising the 95-108 amino acid sequence (SQWNKP) of the 133 PrP protein (27) . 134 135
Western-blot (WB) of the abnormal PrP 136
PK resistant abnormal PrP extraction (PrP res ) and Western blot were performed as previously described (5), 137 using a commercial extraction kit (Biorad, France). PrP immunodetection was performed using either Sha31 138 monoclonal antibody (0,06 µg per mL, epitope: YEDRYYRE , amino acid 145-152) or 12B2 (4 µg/mL) 139 (epitope WGQGG, amino acid sequences 93-97) (19) . 140
For glycoprofiling of the PrP res , signal volume and relative percentage associated with each band was 141 established using Quantity One ® software (Bio-Rad) following immunoblot. For each sample, three 142 independent measures were realized on three different gels. 143 144 8
Results
146
Oral challenge in goats 147
Our first oral challenge experiment in goats was designed to establish the scheme and kinetics of PrP Sc 148 dissemination in the tissues of Wild type (WT) PRNP genotype animals. For that purpose, goat kids 149 obtained by natural mating of WT PRNP genotype goats and bucks were orally challenged within the first 150 48 hours following birth. Groups of these animals were culled at different time point after inoculation 151 (Table 1) . PrP
Sc accumulation was first observed in the gut associated lymphoid tissue (Peyer's patches) in 152 animals more than 180 dpi. As already described in sheep, PrP
Sc progressively spread to all lymphoid organs 153 before becoming detectable (between 180 and 360 dpi) in the enteric nervous system (ENS) and later 154 (between 540 and 940 dpi) in the central nervous system (3). 155
On the basis of these results, a second oral challenge experiment was designed. The goal of this experiment 156 was to characterize the impact of the investigated polymorphisms on the susceptibility and the PrP Sc 157 dissemination in the tissues of orally exposed animals. Groups of wild type animals and heterozygous 158 I/M 142 , R/Q 211 and Q/K 222 were produced by natural mating and orally challenged using the same procedure 159
and Scrapie isolate than in the first experiment. 160
In this second experiment, the PrP Sc dissemination scheme observed in WT genotype animals was consistent 161
with the results of the first experiment (Table 2) . No PrP Sc deposition was observed in the tissues collected 162 from goats killed at 120dpi. At 360dpi, significant PrP Sc deposition was observed in various lymphoid 163 tissues (Peyer's patches, mesentery lymph nodes and tonsil) of some of the challenged individuals. PrP Sc 164 deposition was observed in ENS, CNS, peripheral nervous tissues and skeletal muscles in four out of the 165 five animals culled at 760 dpi. 166
In the heterozygous I/M 142 orally challenged animals a similar but slightly delayed PrP Sc accumulation 167 scheme was observed; PrP Sc was first detected in the gut associated lymphoid tissue (Peyer's patches) at 168 360dpi but it was only detected at 1040 dpi in the CNS (Table 2) Cases controls studies in classical scrapie affected herds (1, 7, 22, 31, 32, 35) and limited data from 225 experimental challenge (intracerebral routes) (2, 36) supported the view that K 222 PrP allele goats might be 226 strongly resistant to classical scrapie infection. Rare cases of the disease (n=3) were reported in 227 heterozygote K 222 goats belonging to one single flock that displayed a high disease prevalence (27.4%), and 228 no case was reported so far in homozygous K 222 animals (7, 14 allele cannot be considered to provide the same level of resistance against scrapie as the K 222 allele. 255
The lack of H 154 homozygous goats in the intracerebral inoculation experiment clearly limits our capacity to 256 draw final conclusions concerning the level of resistance/susceptibility to classical scrapie associated with 257 this PRNP allele. Nevertheless, the risk of atypical scrapie occurrence has been shown to be significantly 258 higher in both H 154 allele carrier sheep and goat (same PrP C sequence in goats and sheep) than in WT 259 animals (13, 28). This higher susceptibility to atypical scrapie represents a major argument against the 260 selection of the H 154 PRNP allele in goat population 261
Beyond this, the main limitation of this experiment is the fact that only one classical scrapie goat isolate was 262 used to test the relative susceptibility of the different genotypes. The diversity of TSE agents in small 263 ruminants has been documented for several decades (3, 12, 33) . In sheep, the susceptibility to TSE infection 264 was shown to be influenced by both the nature of the TSE strain and the PRNP polymorphisms (10). 265
Considering the time and the resources necessary to carry out bioassay in large animals, testing several 266 classical scrapie agents in parallel in this model was simply not feasible. In that context, the inoculation of a 267 variety of TSE agent in transgenic mice that express the WT and K 222 PRNP goat alleles will play a pivotal 268 role in confirming the apparent low susceptibility / high resistance associated with this last allele. 269
Finally, it should be noticed that the experimental approach we used only allowed estimating the impact of 270 individual PRNP polymorphisms on the susceptibility to the disease. For obvious material reasons, it was 271 14 not possible to investigate the effect of PRNP haplotypes combinations (like individuals that would bear 272 both Q 211 and K 222 allele). 273
274
The development of PRNP genotype selection programs is now being considered by the EU authorities as a 275 potential tool to control and eradicate scrapie in commercial goat populations. In sheep, the diffusion of the 276 ARR allele in the general population and, in particular, its introduction in classical scrapie affected herds 277 has proven its efficacy for the long term control of the disease (15, 18, 24 
